Alloimmune Red Blood Cell Antibodies: Prevalence Pathogenicity in a Canadian Prenatal Population

Journal of Obstetrics and Gynaecology Canada

Volumn 37, Issue 9, 2015, Pages 784-790

  Zwingerman, Rhonda ^a   Jain, Venu ^a   Hannon, Judith ^a,b   Zwingerman, Nora ^c   Clarke, Gwen ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alloimmunization; Fetal anemia; Isoimmunization; Rhesus

Indexed keywords

ERYTHROCYTE ANTIBODY; AUTOANTIBODY;

ADVERSE OUTCOME; ALLOIMMUNITY; ANTIBODY SCREENING; ANTIBODY TITER; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; FETUS; FETUS DISEASE; FETUS OUTCOME; HEMOLYTIC ANEMIA; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; PATHOGENICITY; POPULATION RESEARCH; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL PERIOD; PREVALENCE; RETROSPECTIVE STUDY; ADULT; BLOOD; ERYTHROCYTE; IMMUNOLOGY; PREGNANCY;

ADULT; AUTOANTIBODIES; CANADA; ERYTHROCYTES; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 84956937295     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30148-1     Document Type: Article

References (25)

1. Queenan J.T., Smith B.D., Haber J.M., Jeffrey J., Gadow H.C. Irregular antibodies in the obstetric patient. Obstet Gynecol 1969, 34(6):767-771.
2. Moise K.J. Fetal anemia due to non-rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008, 13(4):207-214.
3. Eder A.F. Update on HDFN: new information on long-standing controversies. Immunohematology 2006, 22(4):188-195.
4. Queenan J.T. Management of Rh-immunized pregnancies. Prenat Diagn 1999, 19(9):852-855.
5. Judd W.J. Scientific Section Coordinating Committee of the AABB. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion 2001, 41(11):1445-1452.
6. Spinnato J.A. Hemolytic disease of the fetus: a plea for restraint. Obstet Gynecol 1992, 80(5):873-877.
7. Mari G., Deter R.L., Carpenter R.L., Rahman F., Zimmerman R., Moise K.J., et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000, 342(1):9.
8. Koelewijn J.M., Vrijkotte T.G., van der Schoot C.E., Bonsel G.J., de Haas M. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion 2008, 48(5):941-952.
9. Gottvall T., Selbing A., Hilden J.O. Evaluation of a new swedish protocol for alloimmunization screening during pregnancy. Acta Obstet Gynecol Scand 1993, 72(6):434-438.
10. Solola A., Sibai B., Mason J.M. Irregular antibodies: an assessment of routine prenatal screening. Obstet Gynecol 1983, 61(1):25-30.
11. Moise K.J. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000, 92(1):75-81.
12. Hadley A.G. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn. Vox Sang 1998, 74(Suppl 2):375-383.
13. Alberta reproductive health: pregnancies and birth tables update 2011 2011, Alberta Reproductive Health Report Working Group, Alberta Health and Wellness, Edmonton, (AB).
14. Nordvall M., Dziegiel M., Hegaard H.K., Bidstrup M., Jonsbo F., Christensen B., et al. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities. Transfusion 2009, 49(10):2070-2075.
15. Bettelheim D., Panzer S., Reesink H.W., Csapo B., Pessoa C., Guerra F., et al. Monitoring and treatment of anti-D in pregnancy. Vox Sang 2010, 99(2):177-192.
16. Geifman-Holtzman O., Wojtowycz M., Kosmas E., Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997, 89(2):272-275.
17. Belfrage P., Thomassen P., Floberg J., Akerblom O., Broberger U. Allo-immunization during pregnancy. clinical results from 1983 to 1989 in a scandinavian university hospital. Acta Obstet Gynecol Scand 1992, 71(4):273-277.
18. Filbey D., Hanson U., Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central sweden. Acta Obstet Gynecol Scand 1995, 74(9):687-692.
19. Goodrick M.J., Hadley A.G., Poole G. Haemolytic disease of the fetus and newborn due to anti-fy(a) and the potential clinical value of duffy genotyping in pregnancies at risk. Transfus Med 1997, 7(4):301-304.
20. Hackney D.N., Knudtson E.J., Rossi K.Q., Krugh D. O'Shaughnessy RW Management of pregnancies complicated by anti-c isoimmunization. Obstet Gynecol 2004, 103(1):24-30.
21. Kozlowski C.L., Lee D., Shwe K.H., Love E.M. Quantification of anti-c in haemolytic disease of the newborn. Transfus Med 1995, 5(1):37-42.
22. Joy S.D., Rossi K.Q., Krugh D. O'Shaughnessy RW Management of pregnancies complicated by anti-E alloimmunization. Obstet Gynecol 2005, 105(1):24-28.
23. Moran P., Robson S.C., Reid M.M. Anti-E in pregnancy. BJOG 2000, 107(11):1436-1438.
24. van Dijk B.A., Dooren M.C., Overbeeke M.A. Red cell antibodies in pregnancy: there is no 'critical titre'. Transfusion Med 1995, 5(3):199-202.
25. Moise K.J. Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 2008, 112(1):164-176.